An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor

Ben J Gu1, Ronald Sluyter, Kristen K Skarratt

  • 1Department of Medicine, University of Sydney at Nepean Hospital, Penrith, New South Wales 2750, Australia.

Insights

A new P2X7 receptor polymorphism, R307Q, causes loss-of-function by preventing ATP binding. This discovery identifies a third common genetic variant impacting immune cell responses mediated by the P2X7 receptor.

Area of Science:

  • Immunology
  • Molecular Biology
  • Genetics

Background:

  • The P2X7 receptor (P2X7R) is a critical immune cell receptor involved in ATP-induced apoptosis.
  • Known loss-of-function polymorphisms (E496A, I568N) partially explain variations in P2X7R function.
  • Understanding P2X7R genetic variations is crucial for immune system research.

Purpose of the Study:

  • To identify and characterize novel loss-of-function polymorphisms in the human P2X7 receptor.
  • To investigate the functional consequences of a newly identified R307Q polymorphism on P2X7R activity.
  • To determine the impact of this polymorphism on ATP binding and receptor function.

Main Methods:

  • Genotyping of 420 subjects to identify P2X7R polymorphisms.
  • Functional assays measuring ion fluxes (Rb+, Ba2+, ethidium+) in monocytes and lymphocytes.
  • Transfection studies to assess P2X7R protein synthesis, surface expression, and function.
  • Monoclonal antibody binding assays to evaluate receptor-ligand interactions.

Main Results:

  • A novel heterozygous polymorphism, R307Q, was identified in 12 of 420 subjects.
  • The R307Q mutation resulted in absent or markedly decreased P2X7R channel and pore function.
  • R307Q P2X7R exhibited normal protein synthesis and surface expression but failed to bind a specific blocking antibody.
  • Monocyte-to-macrophage differentiation partially restored function in heterozygous R307Q cells, but double heterozygotes (R307Q/I568N) showed complete loss-of-function.

Conclusions:

  • The R307Q polymorphism represents a third significant loss-of-function variant of the human P2X7 receptor.
  • This polymorphism likely abolishes ATP binding to the extracellular domain of P2X7R, impacting immune cell signaling.
  • The findings contribute to understanding genetic variability in immune responses mediated by P2X7R.

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
ATP Driven Pumps II: P-type Pumps01:34

ATP Driven Pumps II: P-type Pumps

The P-type pumps are a large family of integral membrane transporter ATPases. They are divided into five major types based on substrate specificity, from I to V.
A typical P-type pump has three cytosolic domains: nucleotide-binding (N), phosphorylation (P), and activator (A) domains. These domains are connected to the membrane-spanning helices by short amino acid segments. ATP hydrolysis and covalent phosphoenzyme intermediate formation are crucial parts of the catalytic cycle. At the highly...
Allosteric Proteins-ATCase01:19

Allosteric Proteins-ATCase

Binding sites linkages can regulate a protein's function.  For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to  N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...